These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 36332912)

  • 1. HIV: Two in three people have trouble getting PrEP, finds survey.
    Griffin S
    BMJ; 2022 Nov; 379():o2667. PubMed ID: 36332912
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting PrEP to the patients who need it.
    Foley AVA; Farrell DF; Reese PC
    J Fam Pract; 2023 Nov; 72(9):E1-E7. PubMed ID: 37976331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making the most of a fertile PrEP landscape.
    The Lancet Hiv
    Lancet HIV; 2023 Dec; 10(12):e755. PubMed ID: 38040472
    [No Abstract]   [Full Text] [Related]  

  • 4. Equitable access to PrEP is essential to reap its benefits.
    The Lancet Hiv
    Lancet HIV; 2023 Feb; 10(2):e69. PubMed ID: 36731987
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimising PrEP uptake and use in Peru: no time to lose!
    Menacho L; Konda KA; Lecca L; Cabello R; Lankowski A; Benites C; Gallardo-Cartagena JA; Duerr A; Sánchez J; Galea JT
    Lancet HIV; 2024 Apr; 11(4):e204-e206. PubMed ID: 38538157
    [No Abstract]   [Full Text] [Related]  

  • 6. Expansion of PrEP and PEP services in China.
    Wang H; Tang W; Shang H
    Lancet HIV; 2022 Jul; 9(7):e455-e457. PubMed ID: 35688167
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV prevention with PrEP: Challenges and prospects].
    Guyonvarch O; Vaillant L; Hanslik T; Blanchon T; Rouveix E; Supervie V
    Rev Med Interne; 2021 Apr; 42(4):275-280. PubMed ID: 33127173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing HIV Infection in High-Risk Adolescents Using Preexposure Prophylaxis (PrEP).
    Blackwell CW
    J Assoc Nurses AIDS Care; 2018; 29(5):770-774. PubMed ID: 30146018
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on 'HIV transmission and previous PrEP awareness and use in men who have sex with men in Brighton, UK'.
    Norcross C; Fitzpatrick C; Richardson D
    Sex Transm Infect; 2022 Sep; 98(6):461. PubMed ID: 35428701
    [No Abstract]   [Full Text] [Related]  

  • 10. Investing in National HIV PrEP Preparedness.
    Johnson J; Killelea A; Farrow K
    N Engl J Med; 2023 Mar; 388(9):769-771. PubMed ID: 36847476
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-acting PrEP: new opportunities with some drawbacks.
    Xiridou M; Hoornenborg E
    Lancet HIV; 2023 Apr; 10(4):e213-e215. PubMed ID: 36642088
    [No Abstract]   [Full Text] [Related]  

  • 12. PrEP2U: delivering HIV pre-exposure prophylaxis (PrEP) in partnership from a community setting.
    Richardson D; Tweed M; Nichols K; Finn R; Nicholson S; Darking M
    Sex Transm Infect; 2023 Feb; 99(1):70. PubMed ID: 36163165
    [No Abstract]   [Full Text] [Related]  

  • 13. Gender-affirmative systems needed for PrEP implementation.
    Operario D; Restar A
    Lancet HIV; 2020 Dec; 7(12):e799-e800. PubMed ID: 32622371
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Pre-Exposure Prophylaxis (PrEP) Utilization in the Philippine HIV Crisis.
    Alibudbud R
    J Prim Care Community Health; 2023; 14():21501319231163643. PubMed ID: 36945739
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved PrEP Awareness and Use among Trans Women in San Francisco, California.
    Wilson EC; Hernandez CJ; Scheer S; Trujillo D; Arayasirikul S; Sicro S; McFarland W
    AIDS Behav; 2022 Feb; 26(2):596-603. PubMed ID: 34390435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the percentage of European MSM eligible for PrEP: insights from a bio-behavioural survey in thirteen cities.
    Cordioli M; Gios L; Huber JW; Sherriff N; Folch C; Alexiev I; Dias S; Nöstlinger C; Gama A; Naseva E; Valkovičová Staneková D; Marcus U; Schink SB; Rosinska M; Blondeel K; Toskin I; Mirandola M
    Sex Transm Infect; 2021 Nov; 97(7):534-540. PubMed ID: 33441447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis (PrEP).
    Tumarkin E; Siedner MJ; Bogoch II
    BMJ; 2019 Jan; 364():k4681. PubMed ID: 30655299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.